Automated Abdominal Binder for Orthostatic Hypotension

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
Orthostatic HypotensionAutonomic FailurePure Autonomic FailureMultiple System Atrophy
Interventions
DEVICE

automated abdominal binder

The binder automatically inflates every time the participant stands up to apply a compression level of about 40 mmHg. Participants will wear the device throughout the active/sham study day.

DEVICE

Sham binder

The binder automatically inflates every time the participant stands up to apply a compression level of about 5 mmHg. Participants will wear the device throughout the active/sham study day.

DRUG

Placebo

Oral placebo will be given three times a day on the baseline day (placebo)

DRUG

Midodrine

A midodrine pill 10mg will be given three times a day on the standard of care study day

Trial Locations (1)

37232

RECRUITING

Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER